UncategorizedThe stembroids are coming… to transform regenerative medicine Empower Meds / November 21, 2025
UncategorizedCarmat warns of possible insolvency amid critical financial situation – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedAperture Therapeutics develops antisense oligonucleotide targeting CD33 for FTD and ALS – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedBeacon Biosignals deepens partnership with Takeda to improve narcolepsy diagnosis – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedYuvaBio strikes obesity drug discovery deal with Northstrive Empower Meds / November 21, 2025
